Logo image of RENO

Renovare Environmental Inc (RENO) Stock Fundamental Analysis

NASDAQ:RENO - Nasdaq - US09074B1070 - Common Stock

0.1721  -0.05 (-21.77%)

After market: 0.181 +0.01 (+5.17%)

Fundamental Rating

1

Taking everything into account, RENO scores 1 out of 10 in our fundamental rating. RENO was compared to 84 industry peers in the Commercial Services & Supplies industry. RENO may be in some trouble as it scores bad on both profitability and health. RENO is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

RENO had negative earnings in the past year.
RENO Yearly Net Income VS EBIT VS OCF VS FCFRENO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 -5M -10M -15M -20M

1.2 Ratios

Industry RankSector Rank
ROA -51.02%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RENO Yearly ROA, ROE, ROICRENO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 200 -200 400

1.3 Margins

Industry RankSector Rank
OM -55.27%
PM (TTM) -175.04%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RENO Yearly Profit, Operating, Gross MarginsRENO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 -100 -200 -300 -400

0

2. Health

2.1 Basic Checks

RENO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, RENO has more shares outstanding
RENO has a worse debt/assets ratio than last year.
RENO Yearly Shares OutstandingRENO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 10M 20M 30M
RENO Yearly Total Debt VS Total AssetsRENO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M 50M

2.2 Solvency

Based on the Altman-Z score of -5.28, we must say that RENO is in the distress zone and has some risk of bankruptcy.
A Debt/Equity ratio of -0.10 indicates that RENO is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity -0.1
Debt/FCF N/A
Altman-Z -5.28
ROIC/WACCN/A
WACC15.9%
RENO Yearly LT Debt VS Equity VS FCFRENO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 10M -10M 20M 30M

2.3 Liquidity

A Current Ratio of 0.12 indicates that RENO may have some problems paying its short term obligations.
A Quick Ratio of 0.11 indicates that RENO may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.12
Quick Ratio 0.11
RENO Yearly Current Assets VS Current LiabilitesRENO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M

4

3. Growth

3.1 Past

The earnings per share for RENO have decreased strongly by -34.59% in the last year.
The Revenue has grown by 110.03% in the past year. This is a very strong growth!
RENO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 40.65% yearly.
EPS 1Y (TTM)-34.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-342.86%
Revenue 1Y (TTM)110.03%
Revenue growth 3Y54.33%
Revenue growth 5Y40.65%
Sales Q2Q%-46.85%

3.2 Future

RENO is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.54% yearly.
The Revenue is expected to decrease by -17.64% on average over the next years. This is quite bad
EPS Next Y69.16%
EPS Next 2Y31.42%
EPS Next 3Y19.33%
EPS Next 5Y13.54%
Revenue Next Year-44.38%
Revenue Next 2Y-19.89%
Revenue Next 3Y-18.67%
Revenue Next 5Y-17.64%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
RENO Yearly Revenue VS EstimatesRENO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M
RENO Yearly EPS VS EstimatesRENO Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -0.2 -0.4 -0.6 -0.8

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RENO. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RENO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RENO Price Earnings VS Forward Price EarningsRENO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -9.17
RENO Per share dataRENO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6 -0.8

4.3 Compensation for Growth

A more expensive valuation may be justified as RENO's earnings are expected to grow with 19.33% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.42%
EPS Next 3Y19.33%

0

5. Dividend

5.1 Amount

No dividends for RENO!.
Industry RankSector Rank
Dividend Yield N/A

Renovare Environmental Inc

NASDAQ:RENO (6/16/2022, 8:00:01 PM)

After market: 0.181 +0.01 (+5.17%)

0.1721

-0.05 (-21.77%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)04-15 2022-04-15/amc
Earnings (Next)07-05 2022-07-05/amc
Inst Owners6.38%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner Change0%
Market Cap5.68M
Analysts82.5
Price Target3.06 (1678.04%)
Short Float %0.05%
Short Ratio0.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.46
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA -9.17
EPS(TTM)-0.86
EYN/A
EPS(NY)-0.27
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.37
BVpS-0.29
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -51.02%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -55.27%
PM (TTM) -175.04%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity -0.1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.12
Quick Ratio 0.11
Altman-Z -5.28
F-Score4
WACC15.9%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-34.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-342.86%
EPS Next Y69.16%
EPS Next 2Y31.42%
EPS Next 3Y19.33%
EPS Next 5Y13.54%
Revenue 1Y (TTM)110.03%
Revenue growth 3Y54.33%
Revenue growth 5Y40.65%
Sales Q2Q%-46.85%
Revenue Next Year-44.38%
Revenue Next 2Y-19.89%
Revenue Next 3Y-18.67%
Revenue Next 5Y-17.64%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A